LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

↓ Download CSV

CIK 0001005286 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends May 25

In fiscal 2025, LIFECORE BIOMEDICAL, INC. \DE\ reported revenue of $128.87M, up 0.5% from the prior year. The company ran a net loss, with a net margin of -30.0% and a gross margin of 31.3%. It held $232.18M in total assets against $198.12M in total liabilities.

Key ratios (FY2025)

31.3%
Gross margin
-13.4%
Operating margin
-30.0%
Net margin
+0.5%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$128.87M$128.26M$103.27M$111.27M$100.87M$160.07M$557.56M$524.23M$469.78M
Cost of Revenue$88.57M$86.41M$75.28M$72.20M$61.94M$120.68M$476.56M$445.89M$390.56M$410.14M
Gross Profit$40.30M$41.85M$27.98M$39.07M$38.94M$39.39M$81.00M$78.34M$79.21M$66.78M
Operating Income-$17.25M-$8.84M-$21.80M-$11.79M-$8.82M-$25.88M$5.47M$13.59M$14.67M-$20.63M
Net Income-$38.72M$12.01M-$99.56M-$116.72M-$32.29M-$38.19M$411.0K$24.83M$10.59M-$11.64M
EPS (Diluted)$-1.27$0.33$-3.32$-3.97$-1.10$-1.31$0.01$0.89$0.38$-0.43
Total Assets$232.18M$253.96M$253.54M$275.97M$421.31M$498.07M$519.09M$404.70M$358.61M$342.65M
Total Liabilities$198.12M$200.06M$218.46M$204.83M$265.88M$290.07M$248.95M$152.14M$130.46M$130.30M
Shareholders' Equity-$14.20M$11.31M-$4.23M$71.14M$155.42M$208.00M$270.14M$252.56M$226.61M$210.73M
Cash & Equivalents$17.47M$8.46M$19.09M$5.94M$609.0K$2.48M$1.08M$2.90M$6.00M$9.97M
Operating Cash Flow-$206.0K$257.0K-$17.44M-$22.59M$16.47M-$17.04M$16.02M$19.78M$29.84M$20.76M
Capital Expenditures$13.41M$18.39M$26.23M$19.26M$12.21M$44.73M$33.59M$23.00M$39.70M
Shares Outstanding34.82M36.66M29.96M29.47M29.29M29.16M28.61M27.91M27.65M27.04M